 HOUSTON, Sept. 01, 2021 GLOBE NEWSWIRE -- Aravive, Inc. Nasdaq: ARAV, a clinical-stage oncology company developing innovative therapeutics to treat life-threatening diseases, today announced that Gail McIntyre, Ph.D., DABT, Chief Executive Officer of Aravive, and Reshma Rangwala, M.D., Ph.D., Chief Medical Officer of Aravive, will participate in a virtual fireside chat at the H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021. The Companys presentation will be available for viewing on September 13, 2021 at 7:00 AM ET. Aravive will also participate in one-on-one meetings at the conference. 